We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Mini Access System Supports Precise Needle Placement

By MedImaging International staff writers
Posted on 16 Apr 2012
Image: The Euclid Tier 1 Mini Access System (Photo courtesy of Houston Medical Robotics).
Image: The Euclid Tier 1 Mini Access System (Photo courtesy of Houston Medical Robotics).
A sextant-like device for central venous catheter (CVC) placement provides a depth scale to adjust positioning, and fits standard ultrasound (US) transducers for observing needle bearing.

The Euclid Tier 1 Mini Access System is designed to access and/or place a guidewire into a blood vessel located 5-60 mm below the skin surface. The system is portable, hand operated, and used in conjunction with commercially available US imaging systems. When coupled, the clinician has the ability to accurately locate, determine the depth, and insert a needle and guidewire into the selected vessel; US imaging enables the user to determine whether or not the guidewire is placed correctly within the vessel.

Technology limitations, inadequate procedure training and exposure, and varying patient size and morphology have all been identified as co-contributors to the high CVC placement complication rates. Use of US imaging during such procedures has been shown to reduce complications, but is often cumbersome and generally requires additional assistance. The Euclid Tier 1 Mini Access System, specifically designed to overcome these issues, is a product of Houston Medical Robotics (TX, USA), and has been approved by the US Food and Drug Administration (FDA).

“Although numerous applications have been identified, our initial target for the Euclid Tier 1 Mini Access System is reducing complications associated with central venous catheter placement,” said Jeffery J. Sheldon, chairman and CEO of Houston Medical Robotics. “With over 5 million CVCs placed each year - and published complication rates are as high as 26% - we are poised to make a significant impact on healthcare outcomes.”

CVC’s are generally placed into the larger veins, such as the internal jugular vein, the subclavian vein, the axillary vein, or the femoral vein. It is used to administer medication or fluids, obtain blood tests (specifically mixed venous oxygen saturation), and directly obtain cardiovascular measurements such as the central venous pressure (CVP). Other, long-term indications include dialysis, administration of antibiotics, parenteral nutrition (especially in the chronically ill), and chemotherapy. Complications include pneumothorax, central-line associated bloodstream infections (CLABSIs), thrombosis, and hemorrhage.

Related Links:

Houston Medical Robotics


Adjustable Mobile Barrier
M-458
40/80-Slice CT System
uCT 528
High-Precision QA Tool
DEXA Phantom
Breast Localization System
MAMMOREP LOOP

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.